Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Acanthe Développement (ACAN.PA)
Paris, FR
Acanthe Développement operates as a European real estate firm, qualifying for France's SIIC (Sociétés d'Investissements Immobilières Cotées) tax regime. A substantial majority—over 94.99%—of its property holdings are situated in prestigious Parisian neighborhoods. The company's strategic approach centers on meticulous oversight of its high-quality assets and attracting top-tier tenants or partners. This dual focus aims to foster significant capital appreciation and generate consistent returns from its portfolio. Acanthe Développement's shares are publicly traded on NYSE Euronext Paris, within its C compartment, and are also included in the IEIF SIIC-REITS index.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +1.88% | -5.65% | -8.82% | -9.58% | -1.36% | -32.19% | -41.35% | -48.70% | -59.81% | +10.22% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth-38.8% Q4'25: -40.3% (vs Q4'23)
-
EPS growth-27.3% Q4'25: +63.8% (vs Q4'23)
-
FCF margin— Q4'25: +10.5% (vs Q4'23)
-
EBIT margin— Q4'25: -35.2% (vs Q4'23)
-
ROIC— Q4'25: -1.6% (vs Q4'23)
-
Share dilution+0.2% Q4'25: +12.3% (vs Q4'23)
-
Debt / EBITDA-1.27× Q4'25: -0.65× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2003 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
|---|---|---|---|---|---|
| Revenue |
45.67M
est.
|
22.33M
est.
|
17.03M
est.
|
10.50M
est.
|
6.57M
est.
|
| EBITDA |
-21.78M
est.
|
-10.44M
est.
|
-7.96M
est.
|
-5.01M
est.
|
-3.13M
est.
|
| EBIT |
-25.55M
est.
|
-12.25M
est.
|
12.07M
est.
|
-5.88M
est.
|
-3.68M
est.
|
| Net Income |
23.71M
est.
|
8.01M
est.
|
20.13M
est.
|
39.38M
est.
|
14.49M
est.
|
| SGA |
13.74M
est.
|
6.59M
est.
|
5.02M
est.
|
1.96M
est.
|
1.99M
est.
|
| EPS |
0.14
est.
|
0.19
est.
|
0.12
est.
|
0.12
est.
|
0.12
est.
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-27 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-26 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-25 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-21 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-20 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-19 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-18 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-15 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-13 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-12 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-11 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-08 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ludovic Dauphin | Deputy Chief Executive Officer, Deputy MD & Chief Operating Officer | 386.4K | male |
| Alain Edgard Louis Dumenil | Chairman, Director General, Chief Executive Officer & MD | — | male |
| Florence Soucemarianadin | Chief Financial Officer & Administrative and Financial Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ACAN.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
